John D Norris

3PUBLICATIONS
41CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

|Jan 18, 2024
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.

Susan Halabi, Siyuan Guo, Joseph J Park

|Mar 05, 2020
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer.

Kaitlyn J Andreano, Suzanne E Wardell, Jennifer G Baker

Pageof 1

Frequent Collaborators

2 joint publications

Donald P McDonnell

1 joint publications

Susan Halabi

1 joint publications

Siyuan Guo

1 joint publications

Joseph J Park